Fundz

Revere Pharmaceuticals Inc. reported raising $1.21 Million in an initial SEC Form D filing, from an offering of $1.92 Million

PRIVATEJun 21, 2019$1.2M of $1.9M raised

Amount Raised

$1.21 Million

$1.21 Million sold, per SEC Form D (first sale Jun 21, 2019)

Round Type

Seed

ArlingtonHealthcare

Quick answer

Revere Pharmaceuticals Inc. raised $1.21 Million in a Seed round, dated June 21, 2019. Revere Pharmaceuticals Inc. is based in Arlington, Massachusetts, United States.

How much did Revere Pharmaceuticals Inc. raise?
Revere Pharmaceuticals Inc. raised $1.21 Million in a Seed round on June 21, 2019.
What does Revere Pharmaceuticals Inc. do?
Revere Pharmaceuticals is a Boston-based startup leading the way in the development of new cancer treatments targeting Rac1 GTPase, an important target in the progression of different cancers.
Where is Revere Pharmaceuticals Inc. based and how big is it?
Revere Pharmaceuticals Inc. is based in Arlington, Massachusetts, United States.
Who are the decision-makers at Revere Pharmaceuticals Inc?
Fundz holds 1 contact at Revere Pharmaceuticals Inc., including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as Revere Pharmaceuticals Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Ostial Corporation raised $2.7M (Seed) on August 5, 2019.
  • IVXpress, Inc. raised $23M on August 5, 2019.
  • St. Teresa Medical, Inc. raised $2M (Seed) on August 2, 2019.
  • Hormone Health Inc. raised an undisclosed amount on August 1, 2019.
  • Chimerix raised $35M on July 31, 2019.
  • Suneva Medical Inc. raised $2.5M (Seed) on July 31, 2019.

Who to call at Revere Pharmaceuticals Inc., and when

A new round usually means Revere Pharmaceuticals Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Revere Pharmaceuticals Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Revere Pharmaceuticals Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Revere Pharmaceuticals Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Revere Pharmaceuticals Inc.

Location

36 ORVIS ROAD

Arlington, Massachusetts, United States

About

Revere Pharmaceuticals is a Boston-based startup leading the way in the development of new cancer treatments targeting Rac1 GTPase, an important target in the progression of different cancers. R-ketorolac, our lead candidate, is a first-in-class Rac1 inhibitor that shows both clinical and non-clinical evidence of efficacy in ovarian cancer.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Revere Pharmaceuticals Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsJedd L., Executive Officer, DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Revere Pharmaceuticals Inc.'s next move

See what Strategic adds

Revere Pharmaceuticals Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.